482 related articles for article (PubMed ID: 30847984)
1. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.
Swann JW; Garden OA; Fellman CL; Glanemann B; Goggs R; LeVine DN; Mackin AJ; Whitley NT
J Vet Intern Med; 2019 May; 33(3):1141-1172. PubMed ID: 30847984
[TBL] [Abstract][Full Text] [Related]
2. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.
Garden OA; Kidd L; Mexas AM; Chang YM; Jeffery U; Blois SL; Fogle JE; MacNeill AL; Lubas G; Birkenheuer A; Buoncompagni S; Dandrieux JRS; Di Loria A; Fellman CL; Glanemann B; Goggs R; Granick JL; LeVine DN; Sharp CR; Smith-Carr S; Swann JW; Szladovits B
J Vet Intern Med; 2019 Mar; 33(2):313-334. PubMed ID: 30806491
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
[TBL] [Abstract][Full Text] [Related]
4. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
West LD; Hart JR
J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
Piek CJ; van Spil WE; Junius G; Dekker A
BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
[TBL] [Abstract][Full Text] [Related]
6. Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry.
Goggs R; Dennis SG; Di Bella A; Humm KR; McLauchlan G; Mooney C; Ridyard A; Tappin S; Walker D; Warman S; Whitley NT; Brodbelt DC; Chan DL
J Vet Intern Med; 2015; 29(6):1603-10. PubMed ID: 26473338
[TBL] [Abstract][Full Text] [Related]
7. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
Al-Ghazlat S
Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
[TBL] [Abstract][Full Text] [Related]
9. The association of blood lactate concentration with outcome in dogs with idiopathic immune-mediated hemolytic anemia: 173 cases (2003-2006).
Holahan ML; Brown AJ; Drobatz KJ
J Vet Emerg Crit Care (San Antonio); 2010 Aug; 20(4):413-20. PubMed ID: 20731807
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
[TBL] [Abstract][Full Text] [Related]
11. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
Panek CM; Nakamura RK; Bianco D
J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia.
Swann JW; Skelly BJ
J Vet Intern Med; 2015 Jan; 29(1):7-13. PubMed ID: 25586014
[TBL] [Abstract][Full Text] [Related]
13. Canine immune-mediated hemolytic anemia: treatment and prognosis.
Balch A; Mackin A
Compend Contin Educ Vet; 2007 Apr; 29(4):230-8; quiz 239. PubMed ID: 17726852
[TBL] [Abstract][Full Text] [Related]
14. The utility of diagnostic tests for immune-mediated hemolytic anemia.
; MacNeill AL; Dandrieux J; Lubas G; Seelig D; Szladovits B
Vet Clin Pathol; 2019 Oct; 48 Suppl 1():7-16. PubMed ID: 31502273
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.
Goggs R
Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1327-1349. PubMed ID: 32814628
[TBL] [Abstract][Full Text] [Related]
16. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
Gerber B; Steger A; Hässig M; Glaus TM
Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
[TBL] [Abstract][Full Text] [Related]
17. Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia.
Tan E; Bienzle D; Shewen P; Kruth S; Wood D
Vet Clin Pathol; 2012 Mar; 41(1):45-55. PubMed ID: 22315967
[TBL] [Abstract][Full Text] [Related]
18. Centrifugal therapeutic plasma exchange in dogs with immune-mediated hemolytic anemia (2016-2018): 7 cases.
Culler CA; Vigani A; Ripoll AZ; Gareau A; Suter SE
J Vet Emerg Crit Care (San Antonio); 2022 Sep; 32(5):645-652. PubMed ID: 35499963
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
Oggier D; Tomsa K; Mevissen M; Glaus T
Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs.
Bestwick JP; Skelly BJ; Swann JW; Glanemann B; Bexfield N; Gkoka Z; Walker DJ; Silvestrini P; Adamantos S; Seth M; Warland J
J Vet Intern Med; 2022 Jul; 36(4):1267-1280. PubMed ID: 35801263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
